Walgreens, CVS limit sales of children’s medications amid ‘tripledemic’

Walgreens, CVS limit sales of children’s medications amid ‘tripledemic’


A sign is placed near the section for children’s medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.

Fatih Aktas | Anadolu Agency | Getty Images

CVS and Walgreens are limiting how many children’s pain relief medications people can buy at once amid a winter “tripledemic” of respiratory viruses, the companies said Monday.

In a statement, CVS said it is limiting the number of pain relief medications to two. Walgreens customers can buy six over-the-counter pediatric fever reducers, the company said in a statement.

“Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint across the country,” Walgreens said.

The cap applies to products bought online or at the pharmacies, the companies said.

Walmart said in a statement that although the company has seen higher demand for pediatric medication this year, it has been able to meet that demand and no purchase limits are in place.

A spokesperson for the Department of Health and Human Services said the agency had been tracking surging demand for medication.

“Every operating division across HHS is engaged and playing a pivotal role in addressing these concerns,” the spokesperson said in a statement.

In a separate statement, the Food and Drug Administration added that it can’t require companies to manufacture medications, but it is working closely with drugmakers to “understand, mitigate and prevent or reduce the impact of intermittent or increased demand of certain products.

“The FDA understands that manufacturers expect availability to continue to increase in the near future,” the statement said.

Doctors this fall saw an early surge in respiratory illnesses among young children, with babies and preschool-age kids catching the flu and other viruses, including respiratory syncytial virus, or RSV.

Several children’s hospitals in the U.S. also recently detected a severe and invasive form of strep that has killed at least 15 children in the United Kingdom since mid-September.

NEW YORK, NY – DECEMBER 19: A person purchases medicine, Monday, Dec.19, 2022 at a Walgreens, in New York, United States.

Fatih Atkas | Anadolu Agency | Getty Images

As of Monday, 78% of the inpatient beds in nearly 5,000 hospitals across the country were filled, according to data from the Department of Health and Human Services. Nearly the same percentage of intensive care beds were in use, according to the data.

According to data posted Friday by the Centers for Disease Control and Prevention, the number of people catching the flu remained high but had declined in some areas.

The agency recorded nine pediatric deaths last week, bringing the number of children who have died from the illness this season to 30. Overall, the agency estimated 150,000 flu hospitalizations and 9,300 deaths.

The respiratory viruses have hit young children hard because many remained at home after the coronavirus pandemic hit nearly three years ago, leaving their immune systems vulnerable to common illnesses, experts have said.

Valeriya Antonshchuk contributed.



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More